genetic risk assessment in myeloproliferative neoplasms
Published 7 years ago • 770 plays • Length 9:19Download video MP4
Download video MP3
Similar videos
-
26:23
myeloproliferative neoplasms in 2014: morphology, molecular genetics, and test utilization
-
13:39
the role of genetic testing in cardiovascular disease.
-
5:18
genomic testing and risk perception in patients receiving preventive health care.
-
4:36
case 4: risk factors and genetic abnormalities of mpn
-
1:53
what is genetic risk evaluation?
-
10:31
genetic risk assessment by b. korf | openpediatrics
-
18:38
mutation-based risk stratification approaches in myelofibrosis: any real clinical utility?
-
1:25:07
webinar: basics of genetic testing in myeloproliferative neoplasms and understanding test reports
-
8:18
advancements in pml genetic risk assessment
-
8:27
clinically actionable findings from predictive genomic testing
-
7:09
thrombocythemia and polycythemia vera
-
1:23:06
genetic risk assessment and testing
-
2:58
grhpr gene, full gene analysis
-
19:24
making informed decisions about genetic testing
-
4:27
multifactorial inheritance: risk assessment of qualitative traits – genetics | lecturio
-
1:00:44
research to improve genetic risk evaluation and management after diagnosis of cancer: ihpi seminar
-
1:03
mcp 60 seconds with dr ayalew tefferi on myeloproliferative neoplasms
-
30:16
nccm 2024 | epigenetic profiling of biomarkers for cancer risk assessment by dr zdenko herceg
-
1:36
identification of high-risk disease using molecular profiling by mymap